Anixa Biosciences Inc (ANIX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Oct 31
Key ratios (FY2025)
-72.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $210.0K | $210.0K | — | $512.0K | — | $250.0K | $1.11M | $362.5K | $300.0K |
| Operating Income | -$11.70M | -$13.83M | -$11.01M | -$13.88M | -$13.14M | -$9.98M | -$11.89M | -$14.29M | -$6.08M | -$4.51M |
| Net Income | -$10.93M | -$12.55M | -$9.81M | -$13.60M | -$12.95M | -$10.02M | -$11.65M | -$14.00M | -$5.01M | -$5.02M |
| EPS (Diluted) | $-0.34 | $-0.39 | $-0.32 | $0.45 | $-0.45 | — | — | — | — | — |
| Total Assets | $16.08M | $21.59M | $25.52M | $30.41M | $36.26M | $9.45M | $6.29M | $6.45M | $8.81M | $5.63M |
| Total Liabilities | $2.13M | $2.70M | $2.15M | $2.21M | $1.49M | $1.19M | — | — | $889.5K | $4.64M |
| Shareholders' Equity | $15.16M | $20.00M | $24.34M | $29.05M | $35.44M | $8.76M | $5.24M | $5.43M | $7.92M | $987.5K |
| Cash & Equivalents | $1.24M | $1.27M | $915.0K | $12.36M | $29.13M | $6.42M | $3.49M | $3.06M | $3.34M | $2.49M |
| Operating Cash Flow | -$7.17M | -$7.33M | -$6.21M | -$6.49M | -$4.94M | -$6.18M | -$4.74M | -$4.27M | -$3.80M | -$3.38M |
| Capital Expenditures | — | — | — | — | — | $15.8K | $175.5K | $38.4K | $30.2K | $146.5K |
| Shares Outstanding | 33.01M | 32.20M | 31.15M | 30.91M | 30.05M | 24.25M | 20.33M | 18.91M | 16.60M | 8.75M |